Clinical Trial Detail

NCT ID NCT03776487
Title Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Fluorouracil + Oxaliplatin

Nivolumab

Ipilimumab + Nivolumab

Fluorouracil + Ipilimumab + Nivolumab

Age Groups: senior adult

No variant requirements are available.